nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—hypertension—chronic kidney failure	0.586	1	CtDrD
Olmesartan—ABCC2—chronic kidney failure	0.337	1	CbGaD
Olmesartan—AGTR1—nephron—chronic kidney failure	0.00371	0.201	CbGeAlD
Olmesartan—AGTR1—artery—chronic kidney failure	0.00207	0.112	CbGeAlD
Olmesartan—AGTR1—blood plasma—chronic kidney failure	0.00155	0.0842	CbGeAlD
Olmesartan—SLCO1B1—blood plasma—chronic kidney failure	0.00148	0.0802	CbGeAlD
Olmesartan—AGTR1—nephron tubule—chronic kidney failure	0.000801	0.0434	CbGeAlD
Olmesartan—AGTR1—renal system—chronic kidney failure	0.000729	0.0395	CbGeAlD
Olmesartan—AGTR1—cardiovascular system—chronic kidney failure	0.00072	0.039	CbGeAlD
Olmesartan—AGTR1—kidney—chronic kidney failure	0.000704	0.0381	CbGeAlD
Olmesartan—SLCO1B1—renal system—chronic kidney failure	0.000695	0.0376	CbGeAlD
Olmesartan—AGTR1—cortex of kidney—chronic kidney failure	0.000686	0.0372	CbGeAlD
Olmesartan—SLCO1B1—kidney—chronic kidney failure	0.000672	0.0364	CbGeAlD
Olmesartan—ABCC2—nephron tubule—chronic kidney failure	0.000579	0.0314	CbGeAlD
Olmesartan—SLCO1B1—digestive system—chronic kidney failure	0.00057	0.0309	CbGeAlD
Olmesartan—AGTR1—blood—chronic kidney failure	0.000569	0.0308	CbGeAlD
Olmesartan—SLCO1B1—blood—chronic kidney failure	0.000543	0.0294	CbGeAlD
Olmesartan—ABCC2—renal system—chronic kidney failure	0.000527	0.0285	CbGeAlD
Olmesartan—ABCC2—kidney—chronic kidney failure	0.000509	0.0276	CbGeAlD
Olmesartan—Telmisartan—ABCC2—chronic kidney failure	0.000505	0.157	CrCbGaD
Olmesartan—ABCC2—cortex of kidney—chronic kidney failure	0.000496	0.0269	CbGeAlD
Olmesartan—ABCC2—digestive system—chronic kidney failure	0.000432	0.0234	CbGeAlD
Olmesartan—ABCC2—blood—chronic kidney failure	0.000412	0.0223	CbGeAlD
Olmesartan—Telmisartan—CYP2C19—chronic kidney failure	0.000351	0.109	CrCbGaD
Olmesartan—Candesartan—PTGS1—chronic kidney failure	0.000308	0.0959	CrCbGaD
Olmesartan—Irbesartan—PTGS1—chronic kidney failure	0.000308	0.0959	CrCbGaD
Olmesartan—Tasosartan—CYP3A4—chronic kidney failure	0.000274	0.0853	CrCbGaD
Olmesartan—Losartan—ACE—chronic kidney failure	0.000247	0.0769	CrCbGaD
Olmesartan—Valsartan—ALB—chronic kidney failure	0.000207	0.0645	CrCbGaD
Olmesartan—Telmisartan—ABCB1—chronic kidney failure	0.000186	0.0579	CrCbGaD
Olmesartan—Losartan—CYP2C19—chronic kidney failure	0.000182	0.0568	CrCbGaD
Olmesartan—Irbesartan—CYP3A4—chronic kidney failure	0.00018	0.056	CrCbGaD
Olmesartan—Candesartan—ABCB1—chronic kidney failure	0.00015	0.0466	CrCbGaD
Olmesartan—Losartan—CYP3A4—chronic kidney failure	0.000116	0.0361	CrCbGaD
Olmesartan—Losartan—ALB—chronic kidney failure	0.000101	0.0315	CrCbGaD
Olmesartan—Losartan—ABCB1—chronic kidney failure	9.65e-05	0.0301	CrCbGaD
Olmesartan—AGTR1—G alpha (q) signalling events—F2—chronic kidney failure	9.02e-05	0.00163	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	8.99e-05	0.00162	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—F2—chronic kidney failure	8.9e-05	0.00161	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—chronic kidney failure	8.81e-05	0.00159	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	8.73e-05	0.00157	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—NPS—chronic kidney failure	8.62e-05	0.00156	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—DRD1—chronic kidney failure	8.46e-05	0.00153	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	8.43e-05	0.00152	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—chronic kidney failure	8.29e-05	0.0015	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	8.25e-05	0.00149	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	8.19e-05	0.00148	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	8.14e-05	0.00147	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	8.13e-05	0.00147	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—POMC—chronic kidney failure	8.11e-05	0.00146	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	8.08e-05	0.00146	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—chronic kidney failure	8.07e-05	0.00146	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—GCKR—chronic kidney failure	8.02e-05	0.00145	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	8.02e-05	0.00145	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL2—chronic kidney failure	7.94e-05	0.00143	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	7.93e-05	0.00143	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	7.79e-05	0.00141	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	7.73e-05	0.00139	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	7.69e-05	0.00139	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	7.64e-05	0.00138	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	7.57e-05	0.00137	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	7.47e-05	0.00135	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	7.45e-05	0.00134	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	7.31e-05	0.00132	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FABP1—chronic kidney failure	7.23e-05	0.0013	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	7.11e-05	0.00128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	7.03e-05	0.00127	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	6.98e-05	0.00126	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	6.96e-05	0.00126	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	6.87e-05	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGXT—chronic kidney failure	6.85e-05	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GATM—chronic kidney failure	6.85e-05	0.00124	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CRHR1—chronic kidney failure	6.71e-05	0.00121	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	6.7e-05	0.00121	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	6.7e-05	0.00121	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	6.56e-05	0.00118	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ACAT1—chronic kidney failure	6.27e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	6.26e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	6.26e-05	0.00113	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AVP—chronic kidney failure	6.23e-05	0.00112	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	6.19e-05	0.00112	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PTH—chronic kidney failure	6.13e-05	0.00111	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	6.13e-05	0.00111	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CRHR1—chronic kidney failure	6.09e-05	0.0011	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	6.01e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	5.97e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—EDN1—chronic kidney failure	5.93e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL5—chronic kidney failure	5.88e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	5.87e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	5.84e-05	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MLXIPL—chronic kidney failure	5.83e-05	0.00105	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	5.73e-05	0.00103	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—GCKR—chronic kidney failure	5.73e-05	0.00103	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	5.72e-05	0.00103	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	5.66e-05	0.00102	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PTH—chronic kidney failure	5.57e-05	0.00101	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—chronic kidney failure	5.57e-05	0.001	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	5.54e-05	0.001	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	5.44e-05	0.000982	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	5.43e-05	0.00098	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	5.39e-05	0.000972	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	5.39e-05	0.000972	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC22A2—chronic kidney failure	5.33e-05	0.000961	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPY—chronic kidney failure	5.33e-05	0.000961	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	5.32e-05	0.00096	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—chronic kidney failure	5.3e-05	0.000956	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	5.21e-05	0.00094	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	5.16e-05	0.000932	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CRH—chronic kidney failure	5.14e-05	0.000928	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—OXT—chronic kidney failure	5.14e-05	0.000928	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—COL4A5—chronic kidney failure	5.11e-05	0.000921	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic kidney failure	5.02e-05	0.000906	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCG1—chronic kidney failure	4.95e-05	0.000894	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPS—chronic kidney failure	4.87e-05	0.000879	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FABP1—chronic kidney failure	4.86e-05	0.000876	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIP5K1B—chronic kidney failure	4.85e-05	0.000875	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPY—chronic kidney failure	4.84e-05	0.000873	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—DRD1—chronic kidney failure	4.78e-05	0.000862	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ARG2—chronic kidney failure	4.75e-05	0.000857	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TFDP2—chronic kidney failure	4.75e-05	0.000857	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CRH—chronic kidney failure	4.67e-05	0.000842	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—OXT—chronic kidney failure	4.67e-05	0.000842	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LCAT—chronic kidney failure	4.66e-05	0.00084	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIP5K1B—chronic kidney failure	4.65e-05	0.000838	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	4.62e-05	0.000833	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GATM—chronic kidney failure	4.6e-05	0.000831	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGXT—chronic kidney failure	4.6e-05	0.000831	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—F2—chronic kidney failure	4.55e-05	0.000821	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	4.5e-05	0.000812	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	4.5e-05	0.000812	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPS—chronic kidney failure	4.43e-05	0.000798	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—DRD1—chronic kidney failure	4.34e-05	0.000783	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—DDC—chronic kidney failure	4.28e-05	0.000772	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PGF—chronic kidney failure	4.23e-05	0.000763	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—AVP—chronic kidney failure	4.21e-05	0.00076	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACAT1—chronic kidney failure	4.21e-05	0.00076	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	4.16e-05	0.00075	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PRKD1—chronic kidney failure	4.15e-05	0.000749	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PRKAG2—chronic kidney failure	4.15e-05	0.000749	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2B6—chronic kidney failure	4.15e-05	0.000749	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—POMC—chronic kidney failure	4.14e-05	0.000748	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	4.12e-05	0.000743	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	4.09e-05	0.000737	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	4.08e-05	0.000736	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—chronic kidney failure	4.05e-05	0.000731	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	4.04e-05	0.000728	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKAG2—chronic kidney failure	3.98e-05	0.000718	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	3.95e-05	0.000712	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	3.93e-05	0.000708	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	3.92e-05	0.000708	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MLXIPL—chronic kidney failure	3.91e-05	0.000706	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SREBF2—chronic kidney failure	3.89e-05	0.000701	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	3.84e-05	0.000693	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—COL4A3—chronic kidney failure	3.77e-05	0.00068	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCKR—chronic kidney failure	3.75e-05	0.000677	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCC3—chronic kidney failure	3.75e-05	0.000677	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HBEGF—chronic kidney failure	3.69e-05	0.000666	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPIN1—chronic kidney failure	3.67e-05	0.000663	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	3.61e-05	0.000651	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFB1—chronic kidney failure	3.6e-05	0.00065	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LRP2—chronic kidney failure	3.6e-05	0.000649	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2C18—chronic kidney failure	3.6e-05	0.000649	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRHR1—chronic kidney failure	3.6e-05	0.000649	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC22A2—chronic kidney failure	3.58e-05	0.000646	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AVP—chronic kidney failure	3.52e-05	0.000636	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.5e-05	0.000631	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LRP2—chronic kidney failure	3.45e-05	0.000622	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PPARA—chronic kidney failure	3.43e-05	0.000619	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic kidney failure	3.37e-05	0.000609	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDN1—chronic kidney failure	3.35e-05	0.000605	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG1—chronic kidney failure	3.33e-05	0.000601	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL5—chronic kidney failure	3.33e-05	0.0006	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTH—chronic kidney failure	3.29e-05	0.000594	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIP5K1B—chronic kidney failure	3.26e-05	0.000588	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CYBB—chronic kidney failure	3.21e-05	0.000579	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AVP—chronic kidney failure	3.2e-05	0.000577	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	3.19e-05	0.000576	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ARG2—chronic kidney failure	3.19e-05	0.000576	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LCAT—chronic kidney failure	3.13e-05	0.000565	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CPT1A—chronic kidney failure	3.06e-05	0.000552	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—chronic kidney failure	3.04e-05	0.000549	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF23—chronic kidney failure	3.04e-05	0.000548	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL5—chronic kidney failure	3.02e-05	0.000545	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.01e-05	0.000544	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—chronic kidney failure	3e-05	0.000541	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2C19—chronic kidney failure	2.98e-05	0.000538	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LIPC—chronic kidney failure	2.98e-05	0.000538	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.94e-05	0.000531	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	2.92e-05	0.000526	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DDC—chronic kidney failure	2.87e-05	0.000518	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPY—chronic kidney failure	2.86e-05	0.000516	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—AVP—chronic kidney failure	2.83e-05	0.00051	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2B6—chronic kidney failure	2.79e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PRKAG2—chronic kidney failure	2.79e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PRKD1—chronic kidney failure	2.79e-05	0.000503	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—OXT—chronic kidney failure	2.76e-05	0.000498	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRH—chronic kidney failure	2.76e-05	0.000498	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SCARB1—chronic kidney failure	2.76e-05	0.000497	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.75e-05	0.000495	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	2.74e-05	0.000494	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS1—chronic kidney failure	2.73e-05	0.000492	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—chronic kidney failure	2.72e-05	0.000491	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.68e-05	0.000484	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SREBF1—chronic kidney failure	2.68e-05	0.000483	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.65e-05	0.000479	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCF1—chronic kidney failure	2.64e-05	0.000476	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—chronic kidney failure	2.61e-05	0.000472	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SREBF2—chronic kidney failure	2.61e-05	0.000471	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMGCR—chronic kidney failure	2.6e-05	0.00047	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—chronic kidney failure	2.57e-05	0.000464	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DRD1—chronic kidney failure	2.56e-05	0.000463	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.55e-05	0.00046	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FASN—chronic kidney failure	2.55e-05	0.00046	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCKR—chronic kidney failure	2.52e-05	0.000455	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCC3—chronic kidney failure	2.52e-05	0.000455	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CYBA—chronic kidney failure	2.48e-05	0.000448	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPIN1—chronic kidney failure	2.47e-05	0.000445	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.46e-05	0.000443	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.43e-05	0.000438	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LRP2—chronic kidney failure	2.42e-05	0.000436	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C18—chronic kidney failure	2.42e-05	0.000436	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP3A4—chronic kidney failure	2.36e-05	0.000426	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.35e-05	0.000424	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—chronic kidney failure	2.34e-05	0.000422	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—chronic kidney failure	2.33e-05	0.000421	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCA1—chronic kidney failure	2.32e-05	0.000419	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.31e-05	0.000416	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HBEGF—chronic kidney failure	2.18e-05	0.000393	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—chronic kidney failure	2.13e-05	0.000384	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—chronic kidney failure	2.08e-05	0.000375	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CPT1A—chronic kidney failure	2.06e-05	0.000371	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LIPC—chronic kidney failure	2e-05	0.000362	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C19—chronic kidney failure	2e-05	0.000362	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.98e-05	0.000357	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—chronic kidney failure	1.96e-05	0.000354	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCB1—chronic kidney failure	1.91e-05	0.000345	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AVP—chronic kidney failure	1.89e-05	0.000341	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SCARB1—chronic kidney failure	1.85e-05	0.000334	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS1—chronic kidney failure	1.83e-05	0.000331	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.83e-05	0.000329	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—chronic kidney failure	1.82e-05	0.000328	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.8e-05	0.000325	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—chronic kidney failure	1.8e-05	0.000324	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SREBF1—chronic kidney failure	1.8e-05	0.000324	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL5—chronic kidney failure	1.78e-05	0.000322	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1A1—chronic kidney failure	1.76e-05	0.000317	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMGCR—chronic kidney failure	1.75e-05	0.000315	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—chronic kidney failure	1.74e-05	0.000315	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.71e-05	0.000309	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FASN—chronic kidney failure	1.71e-05	0.000309	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGF—chronic kidney failure	1.65e-05	0.000298	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—chronic kidney failure	1.64e-05	0.000296	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARA—chronic kidney failure	1.61e-05	0.00029	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—chronic kidney failure	1.61e-05	0.00029	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP3A4—chronic kidney failure	1.59e-05	0.000286	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.58e-05	0.000285	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCA1—chronic kidney failure	1.56e-05	0.000281	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—chronic kidney failure	1.38e-05	0.000249	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—chronic kidney failure	1.32e-05	0.000238	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—chronic kidney failure	1.31e-05	0.000236	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS1—chronic kidney failure	1.3e-05	0.000235	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCB1—chronic kidney failure	1.28e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—chronic kidney failure	1.26e-05	0.000227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—chronic kidney failure	1.23e-05	0.000222	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—chronic kidney failure	1.22e-05	0.000221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—chronic kidney failure	1.21e-05	0.000218	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—chronic kidney failure	1.2e-05	0.000216	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1A1—chronic kidney failure	1.18e-05	0.000213	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—chronic kidney failure	1.15e-05	0.000207	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—chronic kidney failure	1.14e-05	0.000206	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—chronic kidney failure	1.14e-05	0.000205	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—chronic kidney failure	1.1e-05	0.000199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—chronic kidney failure	1.1e-05	0.000198	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARA—chronic kidney failure	1.08e-05	0.000195	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—chronic kidney failure	1.05e-05	0.000189	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RELA—chronic kidney failure	1.03e-05	0.000186	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—chronic kidney failure	9.24e-06	0.000167	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—chronic kidney failure	8.81e-06	0.000159	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKB1—chronic kidney failure	8.7e-06	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—chronic kidney failure	8.03e-06	0.000145	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—chronic kidney failure	7.89e-06	0.000142	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—chronic kidney failure	7.68e-06	0.000139	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—chronic kidney failure	7.24e-06	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—chronic kidney failure	7.02e-06	0.000127	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—chronic kidney failure	6.71e-06	0.000121	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—chronic kidney failure	5.46e-06	9.85e-05	CbGpPWpGaD
